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The structure of the MarR-family transcription factor NMB1585 from Neisseria
meningitidis has been solved using data extending to a resolution of 2.1 A˚.
Overall, the dimeric structure resembles those of other MarR proteins, with
each subunit comprising a winged helix–turn–helix (wHtH) domain connected
to an -helical dimerization domain. The spacing of the recognition helices of
the wHtH domain indicates that NMB1585 is pre-configured for DNA binding,
with a putative inducer pocket that is largely occluded by the side chains of two
aromatic residues (Tyr29 and Trp53). NMB1585 was shown to bind to its own
promoter region in a gel-shift assay, indicating that the protein acts as an auto-
repressor.
1. Introduction
In Escherichia coli, the multiple antibiotic resistance (mar) locus
regulates the expression of proteins that confer resistance to
numerous exogenous factors such as antibiotics, organic solvents,
oxidative stress and disinfectants (Alekshun et al., 2001; Ellison &
Miller, 2006; Sulavik et al., 1995). Resistance to these antimicrobial
agents or environments is believed to be determined primarily
through the control of efflux pumps with a range of specificities, the
expression of which is controlled locally by the binding of MarR to its
cognate DNA, preventing initiation of gene transcription and thereby
acting as a repressor (Alekshun et al., 2001).
E. coli MarR was the first of the MarR-family regulators to be
described and forms the archetype for a family of homologous
transcriptional regulators which are widely distributed amongst both
archaea and prokaryotes. Some of these homologues are also known
to control mar-type efflux pump operons, e.g. FarR in Neisseria
gonorrhoeae, which controls the expression of the FarAB efflux pump
mediating resistance to long-chain fatty acids (Lee et al., 2003), and
MgrA in Staphylococcus aureus, which controls the expression of
NorA, a multidrug transporter responsible for resistance to fluoro-
quinolones (Truong-Bolduc et al., 2005). In other cases, homologues
have been recruited to different systems and regulate tissue-specific
activities such as the adhesive properties of cells, haemolytic prop-
erties and regulation of protease expression (Ludwig et al., 1995;
Marklund et al., 1992; Perego & Hoch, 1988; Saridakis et al., 2008).
Knowledge of the three-dimensional structures of the MarR-family
regulators has contributed to understanding their mechanism of
action. To date, the structures of more than 20 MarR-family regula-
tors have been solved and deposited in the Protein Data Bank,
including those of E. coli MarR (Alekshun et al., 2001), Bacillus
subtilis OhrR in the unliganded state and bound to its cognate DNA
(Hong et al., 2005), Deinococcus radiodurans HucR (Bordelon et al.,
2006), Enterococcus faecalis SlyA (Wu et al., 2003), Methano-
bacterium thermoautotrophicum MarR in the unliganded state and
with salicylate bound (Saridakis et al., 2008), Pseudomonas aerugi-
nosa MexR (Lim et al., 2002), Sulfolobus tokodaii EmrR (Miyazono
et al., 2007) and Xanthomonas campestris MarR (Chin et al., 2006).
Many of these homologues share less than 20% sequence identity, but
they all possess the same core fold. The proteins are homodimers
comprising a largely helical dimerization domain linked to a DNA-
binding domain that contains a winged helix–turn–helix motif. MarR
proteins repress the activity of their target genes by binding as dimers
to pseudopalindromic sequences in the 10 region of the regulated
promoters. The repressor activity of MarR proteins is modulated by
co-inducer binding, or in the case of OhrR oxidation of cysteines
disrupting disulfide-bridge formation, both of which lead to a major
rearrangement in the dimerization region such that the spacing of the
DNA-binding domains is significantly altered, preventing DNA
recognition.
Neisseria meningitidis encodes two MarR-family repressors,
NMB1853, a homologue of FarR found in N. gonorrhoeae which
presumably also controls expression of the FarRAB efflux pump, and
a second MarR, NMB1585, of unknown function. In N. gonorrhoeae
the close homologue of NMB1585 encoded by NGO1244 has been
shown to be part of the RpoH regulon and is upregulated in response
to temperature stress (Gunesekere et al., 2006). Given the potential
importance of NMB1585 in the pathophysiology of N. meningitidis,
we have targeted this protein for structural studies and in this report
we describe the structure at 2.1 A˚ resolution.
2. Materials and methods
2.1. Protein production and crystallization
The NMB1585 expression construct was generated by means of
ligation-independent cloning using Gateway technology (Invitrogen).
NMB1585 was amplified from genomic DNA (N. meningitidis strain
MC58) with KOD HiFi polymerase (Novagen) using the forward
primer 50-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCT-
GGAAGTTCTGTTCCAGGGCCCGATGAACCAACTCGACCA-
ACTTGGC-30 and the reverse primer 50-GGGGACCACTTTGTA-
CAAGAAAGCTGGGTCTCACTATTTTTTATTTTCCGAGATT-
GTTTTTTC-30. The PCR product was purified using QIAquick 96
plates (Qiagen) and cloned into the expression vector pDEST17 in
two steps according to the manufacturer’s protocol (Invitrogen),
resulting in a construct with an N-terminal His tag and 3C protease
cleavage site. BP and LR reactions were carried out according to the
manufacturer’s instructions. Recombinant LR clones were identified
by PCR using a gene-specific forward primer and a T7 reverse primer
and verified by DNA sequencing. Protein was produced in E. coli
strain B834 (DE3). The cells were grown at 310 K in GS96 media
(QBiogene) to an A600 of 0.6, induced by the addition of 0.5 mM
IPTG and then incubated for a further 20 h at 293 K. The cells were
harvested by centrifugation at 6000g for 15 min and lysed using a
Basic Z Cell Disruptor (Constant Systems Ltd) at 207 MPa in 50 mM
Tris pH 7.5, 500 mM NaCl, 0.2%(v/v) Tween-20. The protein was
purified by nickel-affinity chromatography followed by size-exclusion
chromatography using the standard His Affinity-Gel filtration
program on the A¨KTA 3D (GE Healthcare). After centrifugation at
30 000g for 30 min, the lysate was loaded onto a 1 ml pre-charged
HiTrap Chelating Sepharose FF column (GE Healthcare). The
column was washed with 50 mM Tris pH 7.5, 500 mM NaCl, 20 mM
imidazole. The protein was then eluted in 50 mM Tris pH 7.5, 500 mM
NaCl, 500 mM imidazole and injected onto a 16/60 HiLoad Superdex
200 column (GE Healthcare) equilibrated in 20 mM Tris pH 7.5,
200 mM NaCl. Protein-containing fractions were analyzed on SDS–
PAGE gels (Biorad). The N-terminal tag was removed by overnight
incubation at 277 K with His-tagged 3C protease (prepared from
pET-24/His-3C kindly provided by A. Geerlof, EMBL, Heidelberg).
The 3C protease and any uncleaved protein were removed by nickel-
affinity chromatography and the protein was concentrated to
9.7 mg ml1 using a Vivaspin 15 concentrator with 5 kDa molecular-
weight cutoff (Vivascience) in 20 mM Tris pH 7.5, 200 mM NaCl,
1 mM tris(2-carboxyethyl)phosphine (TCEP). The protein was crys-
tallized using a nanodrop crystallization procedure (Walter et al.,
2005). Crystals were initially obtained in 0.1M HEPES buffer pH 7.5
containing 25%(w/v) PEG 3350, 0.2M ammonium chloride and
growth was optimized by varying the pH of the precipitant by addi-
tion of acid/base as described by Walter et al. (2005). The crystals of
NMB1585 used for data collection were partially dehydrated/cryo-
protected by a three-stage transfer to 40%(w/v) polyethylene glycol
3350, 15%(v/v) ethylene glycol and were flash-frozen in a 100 K
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Figure 1
The structure of NMB1585. (a, b) Ribbon diagrams showing the overall structures
of the NMB1585 monomer and dimer; (c) superposition of NMB1585 dimer
(orange) with the OhrR–DNA complex (PDB code 1z91; blue and green).
nitrogen cold stream prior to data collection. Owing to their superior
diffraction properties compared with methionine-containing native
crystals, data from selenomethionine-labelled crystals were used for
both structure determination and refinement.
2.2. Crystallography methods
Multiwavelength X-ray diffraction data were collected from sele-
nomethionine-labelled NMB1585 crystals on beamline BM14 at the
ESRF, Grenoble. Data were indexed, integrated and scaled using
DENZO and SCALEPACK (Otwinowski & Minor, 1997; Table 1).
The protein was crystallized in space group P21, with two subunits per
asymmetric unit. The selenomethionine substructure of the NMB1585
crystal was solved by multiwavelength anomalous dispersion methods
using SHELXD (Sheldrick, 2008). Three of four possible selenium
sites were thus located and were used to obtain an initial phase set
(SHELXE; phase extension to 2.1 A˚, contrast 0.499, connectivity
0.930, pseudo-free CC 70.64%, mean FOM 0.62). Further density
modification and initial model building were then performed with
RESOLVE (Terwilliger, 2004), yielding a dimeric starting model with
75% of the expected number of residues and 50% of the sequence
threaded. This model was then refined with CNS (Bru¨nger et al.,
1998), iterated with several rounds of rebuilding in O (Jones et al.,
1991). Final statistics are given in Table 1.
2.3. Electrophoretic mobility shift assay
A 378 bp probe corresponding to the intergenic sequence between
NMB1584 andNMB1585 was amplified from genomic DNAusing the
following pair of PCR primers: forward primer 50-CGAACAGG-
ACGTTTCCGGCG-30 and reverse primer 50-CATTGCAAATCA-
GGTTGATACGG-30. A fluorescence-detection method was used for
the electrophoretic mobility shift assay (EMSA), as described by the
manufacturer (Electrophoretic Mobility Shift Assay Kit, Invitrogen).
Briefly, DNA (20 nM) was incubated at room temperature with
increasing amounts of purified NMB1585 protein (up to 640 nM for
the dimeric form) in a total volume of 10 ml containing 1 EMSA
binding buffer (10 mM Tris pH 7.4, 0.1 mM dithiothreitol, 0.1 mM
EDTA, 150 mM KCl). Following the addition of 2 ml 6 EMSA gel-
loading buffer, the samples were loaded onto a pre-cast tris–borate–
EDTA (89 mM Tris base, 89 mM boric acid, 1 mM EDTA pH 8.0) gel
(10%; Invitrogen) that had been pre-equilibrated for 15 min at 120 V
in ice-cold 0.5 TBE running buffer (Invitrogen). The gels were run
at 120 V for 15 min followed by 160 V for a further 70 min. The gels
were stained for 20 min in the dark with SYBR Green EMSA nucleic
acid gel stain in 1 TBE buffer. After washing twice in distilled water
for 10 s each time, the gels were visualized on a UV-light trans-
illuminator using the Gene Genius Bio imaging system (Syngene).
3. Results and discussion
3.1. Overall structure
The structure of NMB1585 was solved to a resolution of 2.1 A˚ by
the multiple-wavelength anomalous dispersion method using seleno-
methionine-substituted protein. Like other members of this family of
regulators, the meningococcal MarR monomer structure is pre-
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Figure 2
Structure-based alignment of NMB1585 with MarR sequences of known structure. The sequences of NMB1585 (N. meningitidis), MarR (E. coli; PDB code 1jgs), OhrR
(B. subtilis; PDB code 1z91) andMTH313 (M. thermoautotrophicum; PDB code 3bpv) were aligned using ClustalW and displayed with secondary structures using ESPript2.2.
The residues proposed to be involved in DNA binding (Gln58, Thr59, Ser61, Arg83) and ligand binding (Tyr29, Trp53) are indicated by arrows.
Table 1
X-ray data-collection and refinement statistics.
Values in parentheses are for the highest resolution shell.
Data set Peak Inflection Remote
Data-collection details
X-ray source ESRF BM14
Wavelength (A˚) 0.97889 0.97912 0.90777
Space group P21
Unit-cell parameters (A˚, ) a = 35.00, b = 64.37, c = 61.07,  = 91.12
Resolution range (A˚) 30.0–2.10 (2.18–2.10)
Unique reflections 14550 (835) 14325 (715) 14294 (763)
Completeness† (%) 90.6 (52.4) 88.9 (44.4) 89.4 (48.1)
Redundancy 8.9 (4.6) 3.3 (1.9) 3.2 (1.9)
Average I/(I) 24.9 (2.0) 15.6 (1.3) 17.4 (1.7)
Rmerge 0.107 (0.494) 0.072 (0.381) 0.063 (0.264)
Refinement statistics
Resolution range (A˚) 30.0–2.10
No. of reflections (working/test) 13531/734
R factor‡ (Rwork/Rfree) 0.203/0.266
No. of atoms (protein/water) 2254/109
R.m.s. bond-length deviation (A˚) 0.008
R.m.s. bond-angle deviation () 1.0
Mean B factor (protein/water) (A˚2) 26/27
† The data are essentially complete to 2.3 A˚ resolution. ‡ Rwork and Rfree are defined
by R =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where hkl are the indices of the reflections (used
in refinement for Rwork; 5% not used in refinement for Rfree) and Fobs and Fcalc are the
structure factors deduced from measured intensities and calculated from the model,
respectively.
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dominantly -helical, with an elongated ‘arm’ domain (1, 5 and 6)
linked to a more compact ‘wing’ domain that contains a winged helix–
turn–helix motif (wHtH; topology 2-t-3-t-4-1-W1-2; Fig. 1).
Consistent with other MarR-family regulators, NMB1585 is dimeric,
with the two wHtH motif-containing ‘wing’ domains distal to the
dimer interface (Figs. 1a and 1b). The dimer interface is thus formed
by a symmetrical interaction of the arm domains of the two mono-
mers and involves contacts between both N-terminal and C-terminal
regions (approximately residues 1–25 and 110–142). The orientation
of the two monomers in the dimer and their ability to pivot relative to
one another has previously been shown to be an essential factor
affecting the DNA-binding mode of MarR-type repressors such as
MexR (Lim et al., 2002), HucR (Bordelon et al., 2006; Wilkinson &
Grove, 2005) and MobR (Hiromoto et al., 2006). More recently, a
comparison of unliganded and DNA-bound forms of OhrR identified
clear conformational changes accompanying DNA binding (Hong
et al., 2005), whilst analysis of M. thermoautotrophicum MarR
(MTH313) crystal structures revealed a large reorientation of the
‘arm’ and ‘wing’ domains accompanying salicylate binding (Saridakis
et al., 2008).
3.2. Comparison with other MarR structures
The structure of NMB1585 was superimposed onto that of the
B. subitilis OhrR–DNA complex and shown to match it closely, with
an r.m.s.d. of 2.4 A˚ for 213 equivalent C atoms of 274 (Fig. 1c). Thus,
NMB1585 appears to be pre-configured for DNA binding, similar to
the structures reported for the HucR regulator of D. radiodurans
(Bordelon et al., 2006) and a MarR-family protein from S. tokodaii
(Kumarevel et al., 2008). However, this does not appear to be typical
amongst other MarR structures (Hong et al., 2005). By reference to
the OhrR structure, the recognition site of NMB1585 is likely to be
approximately 20 bp, with each monomer binding into consecutive
major grooves of the DNA double helix. The residues in the recog-
nition helix (4) that are most likely to be involved in binding in the
major groove of DNA are Gln58, Thr59 and Ser61 (Fig. 2). In the
OhrR complex, a highly conserved arginine (Arg94) residue makes
the key contact between the wing of the wHtH motif and the minor
groove of the DNA target and it has been proposed that this repre-
sents a generic interaction common to all MarR-family proteins
(Hong et al., 2005; Kumarevel et al., 2008). The conformation of the
wing loop of NMB1585 closely resembles that of OhrR and Arg83
would make a similar minor-groove contact (Figs. 1c and 2). It follows
that discrimination between different DNA-binding sites must largely
depend on the sequence and orientation of the recognition helix (4)
of the HtH motif which contacts the major groove of the DNA.
A feature of the MarR family is their capacity to bind to a variety
of effector molecules, generally phenolic compounds such as sali-
cylate; in most cases, this results in a reduction of DNA binding
(Wilkinson & Grove, 2006). The results of cocrystallization experi-
ments have shown that salicylate can bind at two different locations in
MarR proteins. In the structure of E. coliMarR, a salicylate molecule
was observed bound in two surface pockets (termed SalA and SalB)
on each subunit that were located either side of the DNA-recognition
helix (Alekshun et al. (2001). These positions are indicated in the
structure of NMB1585, clearly showing how occupancy is likely to
directly interfere with DNA binding (Fig. 3). However, the residues in
E. coli MarR that form these surface pockets and interact with the
Figure 3
Comparing the salicylate-binding sites of E. coli and M. thermoautotrophicum MarRs with those of NMB1585. (a) Ribbon diagram showing the NMB1585 dimer with the
relative salicylate-binding sites in E. coli (PDB code 1jgs; SalA and SalB) and M. thermoautotrophicum (PDB code 3bpv; Sal1 and Sal2) marked by salicylate molecules
drawn as space-filling objects; (b) and (c) comparison of the M. thermoautotrophicum MarR salicylate-binding sites with the corresponding regions of NMB1585 by
overlapping the two chains separately; the backbones are shown as ribbons and the side chains as sticks, withM. thermoautotrophicum MarR coloured grey and orange and
NMB1585 in blue and cyan; the salicylate molecules are shown as thicker sticks and coloured yellow.
salicylate molecules are not conserved in NMB1585, indicating that
binding to this part of the protein is highly unlikely. In contrast, the
salicylate-binding pocket identified in MTH313, a MarR protein from
M. thermoautotrophicum, is conserved (Saridakis et al., 2008). In the
MTH313 structure one salicylate molecule was observed bound to
each subunit of the dimer at the interface of the DNA-binding
domain and the helical dimerization domain. The two salicylates were
observed to interact at different sites within the binding pocket
(Fig. 3). The positions of the bound salicylates in MTH313 have been
mapped onto the NMB1585 structure and are shown in Fig. 3(a);
detailed views of the two binding sites are shown in the super-
imposition of the two structures (Figs. 3b and 3c). Overlaying of
NMB1585 and MTH313 confirms the presence of a potential ligand-
binding pocket in NMB1585 at a similar location to those in MTH313
and other MarR proteins (Saridakis et al., 2008). However, it is clear
that the side chains of the residues that line the pocket, notably Tyr29,
Tyr36 and Trp53, occupy much of the internal volume of the binding
pocket, which would prevent a ligand such as salicylate from binding
to this conformation of the protein (Figs. 3b and 3c). Therefore, in
order for a ligand to bind into the binding pocket of NMB1585 a
conformational change would have to occur in the protein so that the
dimerization domain moved away from the DNA-binding domain.
This would increase the separation of the 2-helix with respect to 3-
helix in each subunit, thus opening up the hydrophobic pocket.
3.3. DNA binding
The overall structure of NMB1585 confirms that the protein is a
member of the MarR family of transcription repressors. DNA binding
was verified experimentally in an EMSA experiment. Purified
NMB1585 protein showed concentration-dependent binding to a
double-stranded DNA probe corresponding to the region between
the end of the upstream gene (NMB1584) and the start of the coding
sequence for NMB1585 (Fig. 4). This region contains the promoter
for NMB1585 and suggests that, in common with other MarR regu-
lators [e.g. FarR (Lee et al., 2003) and MexR (Evans et al., 2001)],
NMB1585 is an auto-regulator. Two potential DNA–protein com-
plexes were observed in the EMSA experiments: a faster migrating
species at low protein:DNA ratios and a complex of slower mobility
at higher protein:DNA ratios. This suggests that there is more than
one binding site for NMB1585 in the region between the NMB1564
and NMB1565 genes. Typically, MarR regulators bind to relatively
short (pseudo)palindromic sequences consistent with the dimeric
structure of the proteins, although the lengths of the inverted repeats
and the spacing between half-sites is variable (Wilkinson & Grove,
2006). Further experiments would be required, for example DNA
footprinting, to identify the cognate DNA-binding sites of NMB1585.
Interestingly, the addition of salicylate, a prototypical MarR ligand,
did not affect the formation of the protein–DNA complexes (Fig. 4),
suggesting that the protein does not interact with salicylate, in
contrast to E. coli MarR (Alekshun et al., 2001) and MTH313
(Saridakis et al., 2008). This may be explained by the occluded nature
of the putative binding site observed in the crystal structure of
NMB1585 and suggests that the protein may adopt this conformation
in solution.
The physiological role of NMB1585 has not been characterized and
therefore the identity of any natural ligand(s) that may modulate its
activity is unknown. Intriguingly, the gene immediately downstream
of NMB1585 is annotated as a potential integral membrane protein
(NMB1586) classified as a component of an ABC-type multidrug
transport system, ATPase and permease. Transcription analysis of a
NMB1585-knockout strain shows an increase in NMB1586 transcript
expression in the absence of NMB1585 (N. J. Saunders, unpublished
data). Given the role of MarR-family proteins in the regulation of the
expression of efflux systems, it is tempting to speculate that NMB1585
may be a repressor of a transport protein involved in the export of
xenobiotic compounds from Neisseria.
In conclusion, we describe the crystal structure of meningococcal
MarR, which represents a highly adaptable fold widely used in
transcriptional regulation in many bacteria with particular signifi-
cance in controlling responses to changes in their chemical environ-
ment.
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